-
UPCC 30818: A Phase 2 Open-Label Single-Arm Multicenter Study to Assess the Safety and Efficacy of ASP1650 a Monoclonal Antibody ...
The goal of this study is to confirm that an investigational study drug, ASP1650, is both safe and effective as ...
Showing - of trials